BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Board of Directors of Sartorius Stedim Biotech resolves to propose dividend of 0.68 euros per share to Annual Shareholders’ Meeting

  The Board of Directors of Sartorius Stedim Biotech S.A. resolved at today’s meeting to submit a proposal to the combined Annual General Shareholders’ Meeting on March 24, 2021, to pay a dividend for fiscal 2020 of 0.68 euros per share.

  February 5, 2021

   · 

  2 min read
• BioMidwest

  Advanced Clinical Joins Decentralized Trials & Research Alliance (DTRA) to Democratize and Accelerate Clinical Trials

  Advanced Clinical joins a historic alliance of fifty life sciences and healthcare organizations that seeks to accelerate the broad adoption of patient-focused, decentralized clinical trials and research.

  February 5, 2021

   · 

  3 min read
• Deals

  Government of Canada Invests $18 Million to Virtual Health Care Services in British Columbia

  Canada’s universal, publicly funded health care system is a source of pride for Canadians.

  February 5, 2021

   · 

  2 min read
• Deals

  SeaSpine Reports Granting of Inducement Awards - Feb 05, 2021

  SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced that it has issued inducement awards to nine non-executive employees.

  February 5, 2021

   · 

  2 min read
• Deals

  Assertio Holdings, Inc. Announces Pricing of $14 Million Registered Direct Offering

  Assertio Holdings, Inc. announced it has entered into a securities purchase agreement with certain institutional investors to purchase 22,600,000 shares of its common stock at a purchase price of $0.62 per share in a registered direct offering.

  February 5, 2021

   · 

  4 min read
• Chronic Lifestyle Disorders and Improved Healthcare Infrastructure are Key Driving Factors for Development of Peripheral Artery Revascularization Market, finds Fact.MR

  Peripheral arteries are blood vessels which carry blood from heart to arms and legs or organs apart from brain and heart.

  February 5, 2021

   · 

  4 min read
• Investments to Improve Cancer Treatments and Therapeutics is Helping Development of Peritoneal Cancer Treatment Market

  Peritoneal cancer is one of the forms of cancer that occurs more in women, developing a thin sheets of tissue that lines the abdominal wall and gradually covers uterus, bladder, and rectum.

  February 5, 2021

   · 

  4 min read
• Epidermal Cell sheets Sales Surges Due to Growing Need for Effective & Safe Guiding Technology, Says Fact.MR

  Fact.MR, a global research & consulting firm, in their updated edition of the report, indicates that the epidermal cell sheets market is projected for a steady CAGR in 2021 & beyond.

  February 5, 2021

   · 

  4 min read
• Nitric Oxide Management Market Receives Major Impetus amid the COVID-19 Pandemic: Fact.MR Study

  Fact.MR, Rockville: Award winning market research company Fact.MR is conducting an exhaustive study on the global nitric oxide management market.

  February 5, 2021

   · 

  5 min read
• Ocular Drug Delivery System Market: Increasing incidence of ophthalmic disorders is expected to drive the market

  The ocular drug delivery system market is predicted to chart a notable growth trajectory over the forecast period from 2020 to 2030.

  February 5, 2021

   · 

  5 min read